Compression Therapy for HIV-Associated Kaposi Sarcoma Leg Lymphedema: Results of the Kenyan Improvised Compression for Kaposi Sarcoma Randomized Controlled Trial
Aileen Y Chang, Rakhi Karwa, Haji Odhiambo, Phelix Were, Sara L Fletcher, Edith C Tonui, Michael A Kohn, Jeannette Lee, Di Chang, Shelly Lensing, Diana Flora Namaemba, Naftali Busakhala, Samson K Kiprono, Toby Maurer, Suzanne Goodrich, Sonak D Pastakia, Aileen Y Chang, Rakhi Karwa, Haji Odhiambo, Phelix Were, Sara L Fletcher, Edith C Tonui, Michael A Kohn, Jeannette Lee, Di Chang, Shelly Lensing, Diana Flora Namaemba, Naftali Busakhala, Samson K Kiprono, Toby Maurer, Suzanne Goodrich, Sonak D Pastakia
Abstract
Purpose: Evaluate the effectiveness of compression while receiving chemotherapy compared with chemotherapy alone in the treatment of HIV-associated Kaposi sarcoma (KS) lymphedema.
Methods: A randomized controlled trial was conducted in a single oncology clinic in western Kenya (NCT03404297). A computer-generated randomization schedule was used to allocate treatment arms. Randomized block design was used for stratification by lymphedema stage. Participants were HIV positive adults age ≥ 18 years on antiretroviral therapy with biopsy-proven KS associated with leg lymphedema and being initiated on chemotherapy. The intervention was 10 weeks of weekly clinic-based application of two-component paste compression bandages. The primary outcome was change in the Lower Extremity Lymphedema Index (LELI) score from week 0 to week 14. The secondary outcomes were change in the Lymphedema Quality of Life measure (LYMQOL) and change in the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 score from week 0 to week 14. Blinded outcome assessments were conducted.
Results: Of 30 participants randomly assigned, 25 eligible patients (chemotherapy [control], n = 13; compression plus chemotherapy [intervention], n = 12) returned at week 14. Change in LELI, LYMQOL, and EORTC QLQ-C30 scores between week 14 and week 0 did not significantly differ by arm. The mean (standard deviation) change in LELI score was -25.9 (34.6) for the control arm compared with -13.3 (29.5) for the intervention arm, P = .340. The difference (95% CI) in the change in LELI score was -12.6 (-39.3 to 14.1).
Conclusion: Future studies evaluating a 14-week change in LELI for KS lymphedema should assume a standard deviation of approximately 30. Lessons learned from this pilot trial should inform the development of a larger, multicenter trial to evaluate the effectiveness of compression for KS lymphedema.
Conflict of interest statement
Rakhi KarwaConsulting or Advisory Role: Abbott Laboratories, Direct Relief, Becton Dickinson Naftali BusakhalaResearch Funding: Lilly (Inst) Toby MaurerEmployment: Maurer Dermatology AssociatesLeadership: Maurer Dermatology AssociatesStock and Other Ownership Interests: Maurer Dermatology AssociatesHonoraria: Symposia MedicusConsulting or Advisory Role: Medweb Sonak D. PastakiaEmployment: Abbott Laboratories, Becton DickinsonConsulting or Advisory Role: Abbott Laboratories, Becton DickinsonNo other potential conflicts of interest were reported.
Figures
References
- Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, et al. : Cancer incidence following expansion of HIV treatment in Botswana. PLoS One 10:e0135602, 2015
- Mutyaba I, Phipps W, Krantz EM, et al. : A population-level evaluation of the effect of antiretroviral therapy on cancer incidence in Kyadondo County, Uganda, 1999-2008. J Acquir Immune Defic Syndr 69:481-486, 2015
- Msyamboza KP, Dzamalala C, Mdokwe C, et al. : Burden of cancer in Malawi; common types, incidence and trends: National population-based cancer registry. BMC Res Notes 5:149, 2012
- Semeere A, Wenger M, Busakhala N, et al. : A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma. Cancer Med 5:914-928, 2016
- Rohner E, Valeri F, Maskew M, et al. : Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: A prospective multicohort study. J Acquir Immune Defic Syndr 67:547-554, 2014
- Pellet C, Kerob D, Dupuy A, et al. : Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma. J Invest Dermatol 126:621-627, 2006
- Tulpule A, Groopman J, Saville MW, et al. : Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer 95:147-154, 2002
- Tulpule A, Scadden DT, Espina BM, et al. : Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol 18:716-723, 2000
- Grada AA, Phillips TJ: Lymphedema: Diagnostic workup and management. J Am Acad Dermatol 77:995-1006, 2017
- Vaqas B, Ryan TJ: Lymphoedema: Pathophysiology and management in resource-poor settings - relevance for lymphatic filariasis control programmes. Filaria J 2:4, 2003
- Franks PJ, Moffatt CJ, Doherty DC, et al. : Assessment of health-related quality of life in patients with lymphedema of the lower limb. Wound Repair Regen 14:110-118, 2006
- Stolldorf DP, Dietrich MS, Ridner SH: A comparison of the quality of life in patients with primary and secondary lower limb lymphedema: A mixed-methods study. West J Nurs Res 38:1313-1334, 2016
- Brambilla L, Tourlaki A, Ferrucci S, et al. : Treatment of classic Kaposi's sarcoma-associated lymphedema with elastic stockings. J Dermatol 33:451-456, 2006
- Chang AY, Tonui EC, Momanyi D, et al. : Development of low-cost locally sourced two-component compression bandages in western Kenya. Dermatol Ther (Heidelb) 8:475-481, 2018
- Chang AY, Karwa R, Busakhala N, et al. : Randomized controlled trial to evaluate locally sourced two-component compression bandages for HIV-associated Kaposi sarcoma leg lymphedema in western Kenya: The Kenyan Improvised Compression for Kaposi Sarcoma (KICKS) study protocol. Contemp Clin Trials Commun 12:116-122, 2018
- Campisi C: Lymphoedema: Modern diagnostic and therapeutic aspects. Int Angiol 18:14-24, 1999
- Campisi C, Boccardo F, Zilli A, et al. : Peripheral lymphedema: New advances in microsurgical treatment and long-term outcome. Microsurgery 23:522-525, 2003
- Yamamoto T, Matsuda N, Todokoro T, et al. : Lower extremity lymphedema index: A simple method for severity evaluation of lower extremity lymphedema. Ann Plast Surg 67:637-640, 2011
- Keeley VC S, Locke J, Veigas D, et al. : A quality of life measure for limb lymphoedema (LYMQOL). J Lymphoedema 5:26-37, 2010
- Aaronson NK, Ahmedzai S, Bergman B, et al. : The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
- Aggithaya MG, Narahari SR, Vayalil S, et al. : Self care integrative treatment demonstrated in rural community setting improves health related quality of life of lymphatic filariasis patients in endemic villages. Acta Trop 126:198-204, 2013
- Douglass J, Graves P, Gordon S: Self-care for management of secondary lymphedema: A systematic review. PLoS Negl Trop Dis 10:e0004740, 2016
- Jullien P, Some J, Brantus P, et al. : Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso. Acta Trop 120:S55-S61, 2011. (suppl 1)
- Narahari SR, Bose KS, Aggithaya MG, et al. : Community level morbidity control of lymphoedema using self care and integrative treatment in two lymphatic filariasis endemic districts of South India: A non randomized interventional study. Trans R Soc Trop Med Hyg 107:566-577, 2013
- Wijesinghe RS, Wickremasinghe AR, Ekanayake S, et al. : Efficacy of a limb-care regime in preventing acute adenolymphangitis in patients with lymphoedema caused by bancroftian filariasis, in Colombo, Sri Lanka. Ann Trop Med Parasitol 101:487-497, 2007
- Negussie H, Kassahun MM, Fegan G, et al. : Podoconiosis treatment in northern Ethiopia (GoLBet): Study protocol for a randomised controlled trial. Trials 16:307, 2015
- Negussie H, Molla M, Ngari M, et al. : Lymphoedema management to prevent acute dermatolymphangioadenitis in podoconiosis in northern Ethiopia (GoLBeT): A pragmatic randomised controlled trial. Lancet Glob Health 6:e795-e803, 2018
- Ridner SH, Fu MR, Wanchai A, et al. : Self-management of lymphedema: A systematic review of the literature from 2004 to 2011. Nurs Res 61:291-299, 2012
Source: PubMed